Drones could deliver medical supplies to hospitals under North Carolina proposal

North Carolina has applied for a federal program to test how drones could be used for various purposes. In this case, that purpose would be delivering supplies like blood to hospitals and clinic around the state.

According to the Raleigh News & Observer, the proposal would involve private drone delivery companies setting up distribution centers to make medical deliveries, which the state’s director of aviation, Bobby Walston, said could “allow doctors and hospitals to save more lives.”

The state’s proposal is one of about 210 applications to the Drone Integration Pilot Program at the Federal Aviation Administration. About 10 applications will be chosen, though the North Carolina Department of Transportation (NCDOT) couldn’t say how soon deliveries would begin if the state wins federal funding.

“We don’t exactly know when you’ll see these drones flying around here, but the technology that we’re trying to do already exists,” said NCDOT spokesman James Perace. “They’re doing it in Europe. They’re doing it in Africa.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.